Single App knock-in mouse models of Alzheimer’s disease

Saito, Takashi, Matsuba, Yukio, Mihira, Naomi, Takano, Jiro, Nilsson, Per, Itohara, Shigeyoshi, Iwata, Nobuhisa, Saido, Takaomi C·2014·Nature Neuroscience

Cited by (1,333)

Items 701–800 of 1,333

  1. Detection of sex‐specific glutamate changes in subregions of hippocampus in an early‐stage Alzheimer's disease mouse model using GluCEST MRI
    Narayan Datt Soni, Anshuman Swain, Halvor M. Juul, Quy Cao, Mohammad Haris, David A. Wolk, Virginia M.‐Y. Lee, John A. Detre, Ravi Prakash Reddy Nanga, Ravinder D Reddy · 2024 · Alzheimer s & Dementia
  2. Dual-ligand fluorescence microscopy enables chronological and spatial histological assignment of distinct amyloid-β deposits
    Therése Klingstedt, Hamid Shirani, Farjana Parvin, Sofie Nyström, Per Hammarström, Caroline Graff, Martin Ingelsson, Rubén Vidal, Bernardino Francesco Ghetti, Dag Sehlin et al. · 2024 · Journal of Biological Chemistry
  3. An Overview of Transgenic Mouse Models for the Study of Alzheimer’s Disease
    Paula A. Lopes, Mafalda Soares Pádua, José Luis Guil‐Guerrero · 2025 · Journal of dementia and Alzheimer's disease
  4. A versatile mouse model to advance human microglia transplantation research in neurodegenerative diseases
    Lutgarde Serneels, Annerieke S. R. Sierksma, Emanuela Pasciuto, Ivana Geric, Arya Lekshmi Nair, Anna Martínez‐Muriana, An Snellinx, Bart De Strooper · 2025 · Molecular Neurodegeneration
  5. Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentration environment in Alzheimer's disease
    Shuge Gui, Fan Zeng, Zhou Wu, Saori Nonaka, Tomomi Sano, Junjun Ni, Hiroshi Nakanishi, Masafumi Moriyama, Takashi Kanematsu · 2025 · Journal of Alzheimer s Disease
  6. High-affinity transferrin receptor binding improves brain delivery of bispecific antibodies at tracer dose
    Gillian Bonvicini, S. Gojendra Singh, Lisa Sandersjöö, Tiffany D. Dallas, Eva Schlein, Amelia D. Dahlén, Sara Lopes van den Broek, Dag Sehlin, Ken G. Andersson, Stina Syvänen · 2025 · Fluids and Barriers of the CNS
  7. Cytoskeleton Protein EB3 Contributes to Dendritic Spines Enlargement and Enhances Their Resilience to Toxic Effects of Beta-Amyloid
    Ekaterina I. Pchitskaya, Anastasiya Rakovskaya, Margarita Chigray, Безпрозванный Илья Борисович · 2022 · International Journal of Molecular Sciences
  8. Modifying Dietary Protein Impacts mTOR Signaling and Brain Deposition of Amyloid β in a Knock-In Mouse Model of Alzheimer Disease
    Julien Bensalem, Leanne K. Hein, Sofia Hassiotis, Paul J. Trim, Christopher G. Proud, Leonie Kaye Heilbronn, Timothy J. Sargeant · 2023 · Journal of Nutrition
  9. Functions and distribution of calpain-calpastatin system components in brain during mammal ontogeny
    Irina M. Kotova, Nina S. Pestereva, Dmitrii S. Traktirov, Margarita T. Absalyamova, Marina N. Karpenko · 2023 · Biochimica et Biophysica Acta (BBA) - General Subjects
  10. Alzheimer’s Disease and Age-Related Changes in the Cu Isotopic Composition of Blood Plasma and Brain Tissues of the APPNL-G-F Murine Model Revealed by Multi-Collector ICP-Mass Spectrometry
    Kasper Hobin, Marta Costas‐Rodríguez, Elien Van Wonterghem, Roosmarijn E. Vandenbroucke, Frank Vanhaecke · 2023 · Biology
  11. Prenatal stress aggravates age-dependent cognitive decline, insulin signaling dysfunction, and the pro-inflammatory response in the APPNL-F/NL-F mouse model of Alzheimer's disease
    Ewa Trojan, Katarzyna Curzytek, Paulina Cieślik, Joanna Monika Wierońska, Johannes Gräff, Władysław Lasoń, Takashi Saito, Takaomi C. Saido, Agnieszka Basta‐Kaim · 2023 · Neurobiology of Disease
  12. Feasibility and therapeutical potential of local intracerebral encapsulated cell biodelivery of BDNF to AppNL−G−F knock-in Alzheimer mice
    Simone Tambaro, Sumonto Mitra, Ruchi Gera, Bengt Linderoth, Lars U. Wahlberg, Taher Darreh‐Shori, Homira Behbahani, Per Nilsson, Maria Eriksdotter · 2023 · Alzheimer s Research & Therapy
  13. The Use of Zebrafish in Transcriptome Analysis of the Early Effects of Mutations Causing Early Onset Familial Alzheimer’s Disease and Other Inherited Neurodegenerative Conditions
    Michael T. Lardelli, Lachlan Baer, Nhi Hin, Angel G Allen, Stephen Pederson, Karissa Barthelson · 2023 · Journal of Alzheimer s Disease
  14. Lipid imaging of Alzheimer's disease pathology
    Jörg Hanrieder · 2024 · Journal of Neurochemistry
  15. Neuronal glutathione depletion elevates the Aβ42/Aβ40 ratio and tau aggregation in Alzheimer's disease mice
    Khairun Nisa Binti Hashim, Yukio Matsuba, Mika Takahashi, Naoko Kamano, Ikuo Tooyama, Takaomi C. Saido, Shoko Hashimoto · 2024 · FEBS Letters
  16. Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease
    Wenyan Lü, Francis Shue, Aishe Kurti, Suren Jeevaratnam, Jesse R. Macyczko, Bhaskar Roy, Taha Izhar, Ni Wang, Guojun Bu, Takahisa Kanekiyo et al. · 2024 · Neurobiology of Aging
  17. Exploring the Aβ Plaque Microenvironment in Alzheimer’s Disease Model Mice by Multimodal Lipid-Protein-Histology Imaging on a Benchtop Mass Spectrometer
    Elisabeth Müller, Thomas Enzlein, Dagmar Niemeyer, Livia von Ammon, Katherine A. Stumpo, Knut Biber, Corinna Klein, Carsten Hopf · 2025 · Pharmaceuticals
  18. In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [11C]HSP990 in Healthy Aging and Neurodegeneration
    Romy Cools, Koen Vermeulen, Eline Vonck, Veerle Baekelandt, Cassis Varlow, Valeria Narykina, Christopher Cawthorne, Koen Van Laere, Wim Vanduffel, Neil Vasdev et al. · 2025 · Journal of Nuclear Medicine
  19. Drug Development for Neurodegenerative Diseases
    Yoshitaka Nagai, Eiko Nakano Minakawa · 2015 · Springer eBooks
  20. Benefits of Exercise and Astaxanthin Supplementation: Are There Additive or Synergistic Effects?
    Leandro Kansuke Oharomari, Mitsushi J. Ikemoto, Dong Joo Hwang, Hikaru Koizumi, Hideaki Soya · 2021 · Antioxidants
  21. SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex
    Jennifer L. Brown, Damyan W. Hart, Gabriel E. Boyle, Taylor G. Brown, Michael LaCroix, Andrés M. Baraibar, Ross J. Pelzel, Minwoo Kim, Mathew A. Sherman, Samuel A. Boes et al. · 2022 · Acta Neuropathologica Communications
  22. Brain p3‐Alcβ peptide restores neuronal viability impaired by Alzheimer's amyloid β‐peptide
    Saori Hata, Haruka Saito, Takeharu Kakiuchi, Dai Fukumoto, Shigeyuki Yamamoto, Kensaku Kasuga, Ayano Kimura, Koichi Moteki, Ruriko Abe, Shungo Adachi et al. · 2023 · EMBO Molecular Medicine
  23. Molecular Mechanisms of Amyloid-β Self-Assembly Seeded by In Vivo-Derived Fibrils and Inhibitory Effects of the BRICHOS Chaperone
    Rakesh Kumar, Luis Enrique Arroyo‐García, Shaffi Manchanda, Laurène Adam, Giusy Pizzirusso, Henrik Biverstål, Per Nilsson, André Fisahn, Jan Johansson, Axel Abelein · 2023 · ACS Chemical Neuroscience
  24. Divergent Age-Dependent Conformational Rearrangement within Aβ Amyloid Deposits in APP23, APPPS1, and App NL-F Mice
    Farjana Parvin, Samuel Haglund, Bettina M. Wegenast‐Braun, Mathias Jucker, Takashi Saito, Takaomi C. Saido, K. Peter R. Nilsson, Per Nilsson, Sofie Nyström, Per Hammarström · 2024 · ACS Chemical Neuroscience
  25. Extracellular Release of ILEI/FAM3C and Amyloid-β Is Associated with the Activation of Distinct Synapse Subpopulations
    Masaki Nakano, Yachiyo Mitsuishi, Lei Liu, Naoki Watanabe, Emi Hibino, Saori Hata, Takashi Saito, Takaomi C. Saido, Shigeo Murayama, Kensaku Kasuga et al. · 2021 · Journal of Alzheimer s Disease
  26. Tooth Loss Induces Memory Impairment and Glial Activation in Young Wild-Type Mice
    Ferdous Taslima, Mona Abdelhamid, Chunyu Zhou, Yuxin Chen, Cha‐Gyun Jung, Makoto Michikawa · 2022 · Journal of Alzheimer s Disease Reports
  27. Animal Models of Alzheimer’s Disease
    Shoshik Amram, Dan Frenkel · 2017 · Elsevier eBooks
  28. Role for cell death pathway in Alzheimer’s disease
    Daniel W. Sirkis, Jennifer S. Yokoyama · 2023 · Science
  29. Retinal Vascular and Structural Changes in the Murine Alzheimer’s APPNL-F/NL-F Model from 6 to 20 Months
    Lídia Sánchez-Puebla, Inés López‐Cuenca, Elena Salobrar‐García, María González-Jiménez, Alberto Arias Vázquez, José A. Matamoros, Ana Isabel Ramirez, José A. Fernández‐Albarral, Lorena Elvira‐Hurtado, Takaomi C. Saido et al. · 2024 · Biomolecules
  30. Metabolic resistance of Aβ3pE-42, a target epitope of the anti-Alzheimer therapeutic antibody, donanemab
    Nobuhisa Iwata, Satoshi Tsubuki, Misaki Sekiguchi, Kaori Watanabe-Iwata, Yukio Matsuba, Naoko Kamano, Ryo Fujioka, Risa Takamura, Naoto Watamura, Naomasa Kakiya et al. · 2024 · Life Science Alliance
  31. A three dimensional immunolabeling method with peroxidase-fused nanobodies and fluorochromized tyramide-glucose oxidase signal amplification
    Kenta Yamauchi, Masato Koike, Hiroyuki Hioki · 2025 · Communications Biology
  32. An improved immunoassay detects Aβ oligomers in human biofluids: their CSF levels rise with tau and phosphotau levels
    Ting Yang, Yi Ran Xu, Shan‐Xue Jin, Nagendran Ramalingam, Jean‐Pierre Bellier, Alexandra M Lish, Beth L. Ostaszewski, Tracy L. Young‐Pearse, Lei Liu, Hyun‐Sik Yang et al. · 2025 · Alzheimer s Research & Therapy
  33. Early tactile stimulation influences the development of Alzheimer's disease in gestationally stressed APP NL-G-F adult offspring mice
    Shakhawat R. Hossain, Hadil Karem, Zahra Jafari, Bryan E Kolb, Majid H. Mohajerani · 2023 · Experimental Neurology
  34. VGLUT2 and APP family: unraveling the neurobiochemical mechanisms of neurostimulation therapy to STZ-induced diabetes and neuropathy
    Yitong Zhang, Chenxuan Wu, Wenqi Jiang, Yan Wei Cao, Dongtai Chen · 2024 · Frontiers in Endocrinology
  35. Disturbance in the protein landscape of cochlear perilymph in an Alzheimer’s disease mouse model
    Masatoshi Fukuda, Hiroki Okanishi, Daisuke Ino, Kazuya Ono, Satoru Kawamura, Eri Wakai, Tsuyoshi Miyoshi, Takashi Sato, Yumi Ohta, Takashi Saito et al. · 2024 · PLoS ONE
  36. Clioquinol rescues yeast cells from Aβ42 toxicity via the inhibition of oxidative damage
    Qiaoqiao Zheng, Hongzheng Zhu, Chunyi Lv, Ziting Zhu, Hanyue Cui, Zheyu Fan, Jing Sun, Zhiwei Huang, Ping Shi · 2024 · Biotechnology Journal
  37. House dust mite-induced asthma exacerbates Alzheimer’s disease changes in the brain of the AppNL-G-F mouse model of disease
    Bijayani Sahu, Suba Nookala, Angela Marie Floden, Nilesh Sudhakar Ambhore, Venkatachalem Sathish, Marilyn G. Klug, Colin Kelly Combs · 2024 · Brain Behavior and Immunity
  38. The NRF2 inducer CDDO-2P-Im provokes a reduction in amyloid β levels in Alzheimer’s disease model mice
    Akira Uruno, Shiori Kadoguchi, Ritsumi Saito, Shohei Koiso, Daisuke Saigusa, Ching‐Tung Chu, Takafumi Suzuki, Takashi Saito, Takaomi C. Saido, Antonio Cuadrado et al. · 2024 · The Journal of Biochemistry
  39. Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease
    Dmitry Lim, Carlos Matute, Fabio Cavaliere, Alexei Verkhratsky · 2025 · Handbook of clinical neurology
  40. Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer’s disease models
    Nalini R. Rao, Iván G. Santiago-Marrero, Olivia A. DeGulis, Toshihiro Nomura, Kritika Goyal, SeungEun Lee, Timothy J. Hark, Justin C. Dynes, Emily Dexter, Maciej Dulewicz et al. · 2026 · Science Translational Medicine
  41. Multifunctional Therapeutic Cyclodextrin-Appended Dendrimer Complex for Treatment of Systemic and Localized Amyloidosis
    Masamichi Inoue, Taishi Higashi, Yuya Hayashi, Risako Onodera, Kazuya Fujisawa, Toru Taharabaru, Ryoma Yokoyama, Kenta Ouchi, Yohei Misumi, Mitsuharu Ueda et al. · 2022 · ACS Applied Materials & Interfaces
  42. R-carvedilol, a potential new therapy for Alzheimer’s disease
    Jinjing Yao, S.R. Wayne Chen · 2022 · Frontiers in Pharmacology
  43. Identification of cytoskeletal proteins as binding partners of Bri2 BRICHOS domain
    Makoto Shimozawa, Helene Tigro, Henrik Biverstål, Ganna Shevchenko, Jonas Bergquist, Ruin Moaddel, Jan Johansson, Per Nilsson · 2023 · Molecular and Cellular Neuroscience
  44. Emerging concepts towards a translational framework in Alzheimer’s disease
    Danielle Cozachenco, Eduardo Rigon Zimmer, Mychael V. Lourenco · 2023 · Neuroscience & Biobehavioral Reviews
  45. Nicotine and methyl vinyl ketone, major components of cigarette smoke extracts, increase protective amyloid-β peptides in cells harboring amyloid-β precursor protein
    Yoichi Ohshima, Kazumi Iwata, Masakazu Ibi, Misaki Matsumoto, Masato Katsuyama, Chihiro Yabe‐Nishimura · 2018 · The Journal of Toxicological Sciences
  46. Using stable isotope labeling to advance our understanding of Alzheimer’s disease etiology and pathology
    Timothy J. Hark, Jeffrey N. Savas · 2021 · Journal of Neurochemistry
  47. Assessments of prolonged effects of desflurane and sevoflurane on motor learning deficits in aged AppNL-G-F/NL-G-F mice
    Ryo Niikura, Tomoyuki Miyazaki, Kenkichi Takase, Hiroki Sasaguri, Takashi Saito, Takaomi C. Saido, Takahisa Goto · 2022 · Molecular Brain
  48. Mouse resources at the RIKEN BioResource Research Center and the National BioResource Project core facility in Japan
    Saori Mizuno‐Iijima, Toshiaki Nakashiba, Shinya Ayabe, Hatsumi Nakata, Fumio Ike, Noriko Hiraiwa, Keiji Mochida, Atsuo Ogura, Hiroshi Masuya, Shoko Kawamoto et al. · 2021 · Mammalian Genome
  49. Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
    Arun Upadhyay, Robert J. Vassar, Jeffrey N. Savas · 2022 · Journal of Visualized Experiments
  50. APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer’s Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression
    Takahito Maki, Masahito Sawahata, Ichiro Akutsu, Shohei Amaike, Genki Hiramatsu, Daisuke Uta, Naotaka Izuo, Takahiko Shimizu, Kazuhiro Irie, Toshiaki Kume · 2022 · International Journal of Molecular Sciences
  51. Time-course global proteome analyses reveal an inverse correlation between Aβ burden and immunoglobulin M levels in the APPNL-F mouse model of Alzheimer disease
    Hansen Wang, Declan Williams, Jennifer K. Griffin, Takashi Saito, Takaomi C. Saido, Paul E. Fraser, Ekaterina A. Rogaeva, Gerold Schmitt‐Ulms · 2017 · PLoS ONE
  52. Multi‐omics delineate growth factor network underlying exercise effects in an Alzheimer's mouse model
    Xin Li, Chaozhong Liu, Wenbo Li, Guantong Qi, Yanwan Dai, Chaohao Gu, Yuxiang Sun, Wenjun Zhou, Veronica C. Ciliberto, Jing Liang et al. · 2025 · Alzheimer s & Dementia
  53. Structures and functions of the MICOS: Pathogenesis and therapeutic implications in Alzheimer's disease
    Zihan Wang, Kaige Zhang, Minghao Huang, Dehao Shang, Xiaomin He, Zhou Wu, Yan Xu, Xinwen Zhang · 2025 · Acta Pharmaceutica Sinica B
  54. Oral administration of arginine suppresses Aβ pathology in animal models of Alzheimer's disease
    Kanako Fujii, Toshihide Takeuchi, Yuzo Fujino, Noriko Tanaka, Nao Fujino, Akiko Takeda, Eiko Nakano Minakawa, Yoshitaka Nagai · 2025 · Neurochemistry International
  55. Epigenetic and transcriptomic alterations precede amyloidosis in the Alzheimer’s disease AppNL-G-F knock-in mouse model
    Mariam Okhovat, Cora E. Layman, Brett A. Davis, Alexandra Pederson, Abigail O’Niel, Sarah J. Holden, Kat Kessler, Sonia N. Acharya, Kandace J. Wheeler, Kimberly A. Nevonen et al. · 2025 · Scientific Reports
  56. Blood-brain barrier-penetrative lipid nanoparticles enable systemic delivery of TRIM11 mRNA to disaggregate Tau in Alzheimer’s disease models
    Yan Zou, Yujing Sang, Meng Zheng, Bingyang Shi · 2026 · Cell Reports Medicine
  57. Alzheimer’s disease pathology degrades an NMDA receptor-dependent spontaneous activity pattern in cortico-hippocampal circuits
    Robert A. Ellingford, Sam Harris, Marten Kehring, Rikesh M. Rajani, Francesca Kar Wey Lam, David R. Graykowski, Dorothea Böken, Lindsay A. Welikovitch, Anita Khasnavis, Rhiannon Laban et al. · 2026 · Neuron
  58. APPswe/PS1dE9/Blg Transgenic Mouse Line for Modeling Cerebral Amyloid Angiopathy Associated with Alzheimer’s Disease
    Ekaterina A. Lysikova, Elеna V. Kuzubova, A. I. Radchenko, Evgeny A. Patrakhanov, Kirill Chaprov, Михаил Викторович Корокин, Alexey V. Deykin, Олег Сергеевич Гудырев, М. В. Покровский · 2023 · Molecular Biology
  59. Generation of a tyrosine hydroxylase-2A-Cre knockin non-human primate model by homology-directed-repair-biased CRISPR genome editing
    Sho Yoshimatsu, Junko Okahara, Junko Yoshie, Yoko Igarashi, Ryusuke Nakajima, Tsukasa Sanosaka, Emi Qian, Tsukika Sato, Hiroya Kobayashi, Satoru Morimoto et al. · 2023 · Cell Reports Methods
  60. Temporal Alterations in White Matter in AnAppKnock-In Mouse Model of Alzheimer’s Disease
    Zachery D. Morrissey, Jin Gao, Aashutosh Shetti, Wenping Li, Liang Zhan, Weiguo Li, Igor Fortel, Takaomi C. Saido, Takashi Saito, Olusola Ajilore et al. · 2024 · eNeuro
  61. Telomere length and micronuclei trajectories in APP / PS1 mouse model of Alzheimer's disease: Correlating with cognitive impairment and brain amyloidosis in a sexually dimorphic manner
    Xihan Guo, Jianfei Li, Yanmei Qi, Juanlin Chen, Minyan Jiang, Lina Zhu, Zetong Liu, Han Wang, Gong-Wu Wang, Xu Wang · 2024 · Aging Cell
  62. Effects of Menopause and High Fat Diet on Metabolic Outcomes in a Mouse Model of Alzheimer’s Disease
    Charly Abi‐Ghanem, Abigail E. Salinero, Rachel M. Smith, Richard D. Kelly, Kasey Belanger, Riane Richard, Aaron S. Paul, Ava A. Herzog, Christina A. Thrasher, Krystyna A. Rybka et al. · 2024 · Journal of Alzheimer s Disease
  63. Non-invasive volumetric ultrasound localization microscopy detects vascular changes in mice with Alzheimer's disease
    Rebecca M. Jones, Ryan M. DeRuiter, Mohanish Deshmukh, Paul A. Dayton, Gianmarco Pinton · 2024 · Theranostics
  64. Electrophysiological insights into Alzheimer's disease: A review of human and animal studies
    Kirsten Calvin, Adam M. McNeela, Amanda M. Leisgang Osse, Guncha Bhasin, Matthew Ridenour, Jefferson W. Kinney, J.M. Hyman · 2024 · Neuroscience & Biobehavioral Reviews
  65. Humanized rodent models of neurodegenerative diseases and other brain disorders
    Xinru Zhang, Jianxiang Wang, Jiewen Zhang, Chao Jiang, Xuezhong Liu, Shuaijiang Wang, Zhenhua Zhang, Yousef Rastegar‐Kashkooli, Fatemeh Dialameh, Qinfeng Peng et al. · 2025 · Neuroscience & Biobehavioral Reviews
  66. Interactions between menopause and high‐fat diet on cognition and pathology in a mouse model of Alzheimer's disease
    Charly Abi‐Ghanem, Richard D. Kelly, Emily Groom, Caitlin G. Valerian, Aaron S. Paul, Christina A. Thrasher, Abigail E. Salinero, Molly R. Batchelder, Jennifer J Lafrican, M.-X. Wang et al. · 2025 · Alzheimer s & Dementia
  67. Reactive Astrocytes with Reduced Function of Glutamate Transporters in the App NL-G-F Knock-in Mice
    Ipsit Srivastava, Julen Goikolea, Tamer Ayberk Kaya, María Latorre‐Leal, Francesca Eroli, Marta Pereira Iglesias, Laura Álvarez-Jiménez, Luis Enrique Arroyo‐García, Makoto Shimozawa, Per Nilsson et al. · 2025 · ACS Chemical Neuroscience
  68. Lysine-Targeting Inhibitors of Amyloidogenic Protein Aggregation: A Promise for Neurodegenerative Proteinopathies
    Kazuma Murakami, Thi Hong Van Nguyen, Chioko Nagao, Kenji Mizuguchi, Gal Bitan · 2025 · JACS Au
  69. Cerebral artery dilation during transient ischemia is impaired by amyloid β deposition around the cerebral artery in Alzheimer’s disease model mice
    Nobuhiro Watanabe, Yoshihiro Noda, Taeko Nemoto, Kaori Iimura, Takahiko Shimizu, Harumi Hotta · 2020 · The Journal of Physiological Sciences
  70. Temporal and spatially controlled APP transgene expression using Cre-dependent alleles
    Emily J. Koller, Melissa Comstock, Jonathan Carter Bean, Gabriel Escobedo, Kyung‐Won Park, Joanna L. Jankowsky · 2022 · Disease Models & Mechanisms
  71. Concurrent behavioral and electrophysiological longitudinal recordings for in vivo assessment of aging
    Christopher Daniel Morrone, Arielle A. Tsang, Sarah M. Giorshev, Emily E. Craig, Wai Haung Yu · 2023 · Frontiers in Aging Neuroscience
  72. The KEAP1-NRF2 system and neurodegenerative diseases
    Akira Uruno, Masayuki P. Yamamoto · 2023 · Antioxidants and Redox Signaling
  73. Presymptomatic Reduction of Individuality in the AppNL-F Knockin Model of Alzheimer’s Disease
    Fanny Ehret, Meike S. Pelz, Anna N. Senko, Karla Elizabeth González Soto, Hang Liu, Gerd Kempermann · 2023 · Biological Psychiatry
  74. Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and Spatial Cognition in Alzheimer’s Disease Mice
    Caleigh A. Findley, Samuel McFadden, MaKayla F. Cox, Lindsey N. Sime, Mackenzie R. Peck, Kathleen Quinn, Andrzej Bartke, Kevin N. Hascup, Erin R. Hascup · 2023 · Journal of Alzheimer s Disease
  75. Amyloid plaques and normal ageing have differential effects on microglial Ca2+ activity in the mouse brain
    Pablo Izquierdo, Renaud Jolivet, David Attwell, Christian Madry · 2023 · Pflügers Archiv - European Journal of Physiology
  76. Early and Late Chaperone Intervention Therapy Boosts XBP1s and ADAM10, Restores Proteostasis, and Rescues Learning in Alzheimer’s Disease Mice
    Nirinjini N. Naidoo, Jennifer M. Hafycz, Ewa Strus, Kamalini Sengupta · 2023 · Aging biology
  77. Preclinical Pharmacology and Toxicology - Contributions to the Translational Interface ☆
    Paul McGonigle, Michael J. Williams · 2014 · Elsevier eBooks
  78. Aβ Puts the Alpha in Synuclein
    Casey N. Cook, Leonard Petrucelli · 2020 · Neuron
  79. The Neuroepigenetic Landscape of Vertebrate and Invertebrate Models of Neurodegenerative Diseases
    Thanga Harini Sundaramoorthy, Isabel Castanho · 2022 · Epigenetics Insights
  80. Reduced Autophagy in Aged Trigeminal Neurons Causes Amyloid β Diffusion
    R. Sonoda, E. Kuramoto, S. Minami, Shin‐ei Matsumoto, Yasumasa Ohyagi, Takashi Saito, TC Saido, Kazuyuki Noguchi, Tetsuya Goto · 2023 · Journal of Dental Research
  81. TNIP2 inhibits amyloidogenesis by regulating the 3′UTR of BACE1: An in vitro study
    Long Chen, Lu Wang, Gui‐Feng Zhou, Yue Liu, Xue Chen, Xiao‐Yong Xie, Qi‐Xin Wen, Chen‐Lu Li, Jie Yang, Guojun Chen · 2023 · Neuroscience Letters
  82. Apolipoprotein E genotype-dependent accumulation of amyloid β in APP-knock-in mouse model of Alzheimer's disease
    Yoshiko Takebayashi, Yu Yamazaki, Hidetada Yamada, Kyosuke Yazawa, Masahiro Nakamori, Takashi Kurashige, Hiroyuki Morino, Tetsuya Takahashi, Yusuke Sotomaru, Hirofumi Maruyama · 2023 · Biochemical and Biophysical Research Communications
  83. The long-term effects of heated tobacco product exposure on the central nervous system in a mouse model of prodromal Alzheimer's disease
    Hidetada Yamada, Yu Yamazaki, Yoshiko Takebayashi, Kyosuke Yazawa, Miwako Sasanishi, Atsuko Motoda, Masahiro Nakamori, Hiroyuki Morino, Tetsuya Takahashi, Hirofumi Maruyama · 2024 · Scientific Reports
  84. Solving the Puzzle of Neurodegeneration
    Michael S. Wolfe · 2018 · Elsevier eBooks
  85. Phenotypic evaluation of a childhood-onset parkinsonism-dystonia mouse model with inherent postural abnormalities
    Genesys Giraldo, Christopher Janus · 2020 · Brain Research Bulletin
  86. Accumulation of m 6 A exhibits stronger correlation with MAPT than β-amyloid pathology in an APP NL-G-F /MAPT P301S mouse model of Alzheimer’s disease
    Lulu Jiang, Rebecca Roberts, Melissa Wong, Lushuang Zhang, Chelsea Joy Webber, Alper Kilci, Matthew Jenkins, Guangxin Sun, Sherif Rashad, Jingjing Sun et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Transfixed by transgenics: how pathology assumptions are slowing progress in Alzheimer's disease and related dementia research
    Luciano D'adamio · 2023 · EMBO Molecular Medicine
  88. The UNC5C T835M mutation associated with Alzheimer’s disease leads to neurodegeneration involving oxidative stress and hippocampal atrophy in aged mice
    Devi Krishna Priya Karunakaran, Makenna L. Ley, Joanna Guo, Ammaarah W. Khatri, Katherine R. Sadleir, Jelena Popović, Arun K. Upadhyay, Jeffrey N. Savas, Daniele Procissi, Jasvinder K. Atwal et al. · 2025 · Molecular Neurodegeneration
  89. Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic review
    Luiza Santos Machado, Pedro Rodrigues Vidor, Lavínia Perquim, Christian Limberger, Leonardo Machado, Andréia Silva da Rocha, Carolina Soares, Nesrine Rahmouni, Wagner Scheeren Brum, Bruna Bellaver et al. · 2025 · Molecular Psychiatry
  90. Altered APP trafficking drives amyloidogenic processing in primary neurons from the AppNL-F knock-in mouse model of Alzheimer's disease
    Yang Yu, Robin Ziyue Zhou, Per Nilsson, Bengt G. Winblad, Lars O. Tjernberg, Sophia Schedin‐Weiss · 2025 · Neurobiology of Disease
  91. Advances in non-human primate models for Alzheimer's disease research
    Daisuke Joho, Kenya Sato, Wakako Kumita, Takaomi C. Saido, Erika Sasaki, Hiroki Sasaguri · 2025 · Neuroscience Research
  92. Sex‐specific acceleration of Alzheimer's pathogenesis by chronic sleep‐deprivation
    Darcy Wear, Christopher Daniel Morrone, Dominic Simpson, Fang Liu, S. Abid Hussaini, Wai Haung Yu · 2026 · Alzheimer s & Dementia
  93. Therapeutic potential of isothiocyanates by targeting the NRF2 pathway
    Ángel J. García‐Yagüe, Eduardo Cazalla, Antonio Cuadrado · 2026 · Free Radical Biology and Medicine
  94. Ferroptosis in microglial activation: a systematic review and multidata comparison
    Ida Pesämaa, Srinivas Koutarapu, Henrik Zetterberg, Stefanie Fruhwürth · 2026 · Brain Communications
  95. Cell Type‐Specific Expression of p16, p21, and p53 Reveals Age‐Dependent Glial Senescence in the App NL‐G‐F Mouse Model of Alzheimer's Disease
    Eileen Mac Sweeney, Giulia Abate, Bjorn R. V. Bakker, Andrea Mastinu, Ylenia Lai, Daniela Letizia Uberti, Per Nilsson, Simone Tambaro · 2026 · Aging Cell
  96. Young Adult Microglial Deletion of C1q Reduces Engulfment of Synapses and Partially Mitigates Cognitive Impairment in an Aggressive Alzheimer's Disease Mouse Model
    Tiffany J. Petrisko, Shu‐Hui Chu, Ángela Gómez-Arboledas, Blossom Zhang, Andrea J. Tenner · 2026 · Glia
  97. Effects of high‐fat diet on nutrient metabolism and cognitive functions in young APPKI NL‐G‐F/NL‐G‐F mice
    Wei Wang, Daisuke Tanokashira, Yudai Shibayama, Ryuhei Tsuji, Megumi Maruyama, Chiemi Kuroiwa, Takashi Saito, Takaomi C. Saido, Akiko Taguchi · 2022 · Neuropsychopharmacology Reports
  98. Translational potential of synaptic alterations in Alzheimer’s disease patients and amyloid precursor protein knock-in mice
    Dina Medina Vera, Daniela Enache, Simone Tambaro, Ethar Abuhashish, Cristina Rosell‐Valle, Bengt G. Winblad, Fernando Rodrı́guez de Fonseca, Erika Bereczki, Per Nilsson · 2022 · Brain Communications
  99. Atypical chemokine receptor 3 regulates synaptic removal in disease astrocytes
    Veronica Giusti, Jungjoo Park, Elena Giusto, Laura Masatti, Paula Ramos‐Gonzalez, Ludovica Iovino, Michele Sandre, Aron Emmi, Gurkirat Kaur, Erika Coletto et al. · 2026 · Molecular Neurodegeneration
  100. Cognitive Effects of Simulated Galactic Cosmic Radiation Are Mediated by ApoE Status, Sex, and Environment in APP Knock-In Mice
    Laura Wieg, Jason Ciola, Caroline Wasén, Fidelia Gaba, Brianna R. Colletti, Maren K. Schroeder, Robert G. Hinshaw, Millicent N. Ekwudo, David M. Holtzman, Takashi Saito et al. · 2024 · International Journal of Molecular Sciences